COVID-19 and multisystem inflammatory syndrome in children and adolescents
Document Type
Article
Department
Women and Child Health
Abstract
As severe acute respiratory syndrome coronavirus 2 continues to spread worldwide, there have been increasing reports from Europe, North America, Asia, and Latin America describing children and adolescents with COVID-19-associated multisystem inflammatory conditions. However, the association between multisystem inflammatory syndrome in children and COVID-19 is still unknown. We review the epidemiology, causes, clinical features, and current treatment protocols for multisystem inflammatory syndrome in children and adolescents associated with COVID-19. We also discuss the possible underlying pathophysiological mechanisms for COVID-19-induced inflammatory processes, which can lead to organ damage in paediatric patients who are severely ill. These insights provide evidence for the need to develop a clear case definition and treatment protocol for this new condition and also shed light on future therapeutic interventions and the potential for vaccine development.
Translations: For the French, Chinese, Arabic, Spanish and Russian translations of the abstract see Supplementary Materials section.
Publication ( Name of Journal)
The Lancet Infectious Diseases
Recommended Citation
Jiang, L.,
Tang, K.,
Levin, M.,
Irfan, O.,
Morris, S. S.,
Wilson, K.,
Klein, J. D.,
Bhutta, Z. A.
(2020). COVID-19 and multisystem inflammatory syndrome in children and adolescents. The Lancet Infectious Diseases, 20(11), e276-e288.
Available at:
https://ecommons.aku.edu/pakistan_fhs_mc_women_childhealth_wc/144